GLPG-555
- Generic Name
- GLPG-555
Oral Bioavailability of GLPG0555 in Different Solid Formulations
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2011-01-17
- Last Posted Date
- 2011-03-24
- Lead Sponsor
- Galapagos NV
- Target Recruit Count
- 12
- Registration Number
- NCT01278095
- Locations
- 🇧🇪
SGS Stuivenberg, Antwerp, Belgium
Pharmacokinetics/Pharmacodynamics (PK/PD) of Multiple Oral Doses of GLPG0555 in Healthy Subjects
- First Posted Date
- 2010-09-24
- Last Posted Date
- 2011-03-23
- Lead Sponsor
- Galapagos NV
- Target Recruit Count
- 24
- Registration Number
- NCT01208753
- Locations
- 🇧🇪
SGS Stuivenberg, Antwerp, Belgium
First-in-Human Single Ascending and Multiple Dose of GLPG0555
- First Posted Date
- 2009-12-02
- Last Posted Date
- 2010-08-12
- Lead Sponsor
- Galapagos NV
- Target Recruit Count
- 35
- Registration Number
- NCT01023321
- Locations
- 🇧🇪
SGS Stuivenberg, Antwerp, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath